Loading... Please wait...

Categories

Our Newsletter


PD153035 | EGFR inhibitor

  • PD153035.jpg
  • PD153035, 400x400px, png
Price:
$89.00
Catalog #:
C7153-5
Quantity:


Product Description

PD153035 is an ATP-competitive, quinazoline-based, potent inhibitor of EGFR with an IC50 of 29 pM and Ki of 5.2 pM. [1] PD153035 is selective against PDGFR, FGFR, CSF-1, IR, and Src at concentrations as high as 50 uM. EGF-dependent mitogenesis was inhibited 50% by PD153035 at a concentration of 80 nM. [1]

In cell lines with high levels of EGFR overexpression (Difi, A431, MDA-MB-468), complete inhibition of EGFR autophosphorylation was achieved at concentrations of ?75 nM. In all other EGFR-expressing cell lines, receptor phosphorylation was completely inhibited at dosages of 350 nM or higher. [2]

PD153035 treatment decreases protein expression of iNOS, TNFa, and IL-6, suggesting reduction of M1 proinflammatory state in ATMs, resulting in an improvement in insulin signaling and sensitivity. Prolonged treatment was shown to improve glucose tolerance, reduction in insulin resistance, and a decrease in insulin receptor substrate-1 Ser307 phosphorylation in JNK and inhibition of NF-kB kinase (IKKb) activation. [3]


Technical information:

Chemical Formula:   C16H14BrN3O2.HCl
CAS #:   153436-54-5,183322-45-4
Molecular Weight:   396.67
Purity:   >98%
Appearance:   Off White
Chemical Name:   N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
Solubility:   Up to 10 mM in DMSO
Synonyms:   PD-153035, PD 153035, PD153035, AG 1517, SU 5271

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


Reference:

1. Fry et al., A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science, 1994, 265, 1093-1095. Pubmed ID: 8066447
2. Bos et al., PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin. Cancer Res. 1997, 3, 2099-2106. Pubmed ID: 9815602
3. Prada et al., EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes, 2009, 58(12), 2910-2919. Pubmed ID: 19696185

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the PD153035 | EGFR inhibitor to your wish list.

You Recently Viewed...